Risks during electrode placement
There is a risk that during electrode placement, the electrodes may go all the way through the diaphragm muscle, which could cause air to gather in your chest and cause a capnothorax. If this occurs, air on your chest may cause both discomfort and hinder your ability to breathe.
Risk of lung collapse
In a worst-case situation, one or both of your lungs could collapse. If a lung does collapse, it will be reinflated immediately, using a tube that is placed in your chest. There may be some discomfort and/or bruising at the site where the lead wires go through the skin. This is temporary and should go away in a few days.
Risks of system malfunction
It is possible that stimulation from the diaphragm pacing system could stop, either due to electrode breakage, cable disconnection, or stimulator failure. If one of these happens, breathing will stop. Without prompt attention, this could result in permanent disability or death. This risk is reduced by using back-up electrodes and sounding an alarm whenever the stimulator detects improper operating conditions.
Risk of aspiration
There is a risk of aspiration when using this device. While becoming used to the stimulation and timing, it is recommended that a one-way (Passy-Muir) valve on your tracheostomy is used while eating or drinking when on the pacing device. It is also recommended to use the one-way valve while sleeping to avoid upper airway obstructions. The Passy-Muir speaking valve looks like a plug with holes in it. The valve fits directly onto the end of your tracheostomy tube. It opens during inspiration to let air into your lungs and closes during exhalation to allow air to pass over your vocal cords and out through your nose and/or mouth. The valve allows for more normal respiration, improves swallowing, and may reduce your risk of aspiration.
Increased spasms during adjustment
You may experience increased spasms with the stimulation while your body becomes used to the stimulation. This typically subsides within a few days of use.
Source: Synapse Biomedical Inc.